Medical contrast media market to touch $ 5.17 bn by 2020
The Asia-Pacific market is expected to grow at the highest CAGR during the 2015-2020, says a MarketsandMarkets report
BS B2B Bureau B2B Connect | Dallas, Texas (USA)
The global contrast media/contrast agents market has been segmented on the basis of product, route of administration, indication, procedure, application, and region.
Based on product, the contrast media/contrast agents market is categorised into barium, iodinated, gadolinium, and microbubble contrast media. In 2015, the iodinated contrast media segment is estimated to account for the largest share of the contrast media/contrast agents market, among products. However, the microbubble contrast media segment is expected to grow at the highest CAGR during the 2015-2020 period.
Also Read
Based on indication, the market is segmented into cardiovascular disorders, oncology, gastrointestinal disorders, musculoskeletal disorders, neurological disorders, and nephrological disorders. The cardiovascular disorders segment is estimated to account for the largest share of the global contrast media/contrast agents market (by indication) in 2015.
On the basis of procedure (segmented into X-ray/CT, MRI, and ultrasound), the X-ray/CT segment is expected to account for the largest share of the contrast media/contrast agents market in 2015. However, the ultrasound segment is expected to register the highest CAGR during the given forecast period. The radiology segment is estimated to account for the largest share of the market, among the applications.
While North America is anticipated to account for the largest share of the given market, the Asia-Pacific market is expected to grow at the highest CAGR during the 2015-2020 forecast period, thus serving as a revenue pocket for companies offering contrast media/contrast agents in the near future.
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Jul 07 2015 | 12:24 PM IST